Media Database
>
Patrick Campbell

Patrick Campbell

Assistant Managing Editor at Rheumatology Network

Contact this person
Email address
p*****@*******.comGet email address
Influence score
36
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

rheumatologynetwork.com

Trials Examining Cannabis for Pain Relief Receive Disproportionate Media Coverage, Regardless of ...

A systematic review and meta-analysis assessing more than a dozen double-blind, placebo-controlled trials evaluating cannabis-based products for pain relief suggest these studies were the recipient of a disproportionate level of media coverage that was not associated with the results of each study.
rheumatologynetwork.com

Trial Finds 1-Week Methotrexate Hold As Effective for Vaccine Respo...

A trial comparing a 1-week methotrexate hold following seasonal influenza vaccination against the standard 2-week hold among patients with rheumatoid arthritis using methotrexate suggests there were no significant differences in positive vaccine response with either approach.
rheumatologynetwork.com

Early TNF Inhibitor Initiation in Ankylosing Spondylitis Linked to ...

An analysis of more than 17,000 Veterans suggests early initiation of TNF inhibitor therapy in patients with ankylosing spondylitis was associated with an increased risk of incident cardiovascular disease and major adverse cardiovascular events.
rheumatologynetwork.com

ACR, Vasculitis Foundation Updates Kawasaki Disease Guidelines

“Kawasaki disease continues to be an area of evolving understanding in clinical treatment,” said Mark Gorelik, MD, lead investigator of the guideline.
rheumatologynetwork.com

American Heart Association Issues Advisory on Oral Penicillin in Pa...

The AHA released a statement related to use of oral penicillin for patients with high-risk rheumatic heart disease, including patients with severe mitral stenosis, aortic stenosis, left ventricular systolic dysfunction, or active symptoms of rheumatic heart disease.